Contract Generation

Inefficient Contract Development Processes

Pharmaceutical companies face numerous challenges in generating clinical research contracts, particularly when dealing with outsourcing service providers like CROs. The process is often manual and time-consuming, involving tedious tasks such as cutting and pasting data from awarded proposals into pre-approved contract templates. Information like service descriptions, budgets, and payment schedules must be extracted, re-entered, or rewritten from lengthy proposals, which can exist as Word documents or PDFs. This repetitive work is prone to errors, slows down contract finalization, and requires multiple levels of review before reaching legal approval. Outsourcing specialists are inundated with requests, and with mounting workloads, contract generation timelines often extend to weeks. This not only causes frustration within the company but also delays the execution of clinical trials, adding pressure on all stakeholders involved—especially service providers who depend on timely contract execution to meet their commitments and report backlogs. In an industry already under tight deadlines, these bottlenecks result in avoidable stress and prolonged project timelines, impacting both trial timelines and company efficiency.

SOURCE Automates Contract Creation

Clinical Maestro SOURCE addresses these pain points by automating the contract generation process. The platform uses advanced technology, such as “smart fields look up,” to automatically populate contract templates with data from awarded proposals. Instead of manually cutting and pasting information, the system dynamically inserts service descriptions, budgets, and payment schedules into the appropriate sections of the contract. This automation eliminates the need for repetitive data entry, significantly reducing errors and manual workload. The process is further streamlined with role-based access, allowing stakeholders to easily review documents in real time without the need for constant email inquiries or additional workload on outsourcing teams.

Faster Execution, Fewer Errors

Companies using Clinical Maestro SOURCE have reported over 90% improvements in productivity during the contract generation process. By eliminating manual cut-and-paste tasks and automating document population, contracts are completed faster and with fewer errors. Review times are shortened, and bottlenecks are minimized, allowing clinical trials to begin on schedule. Internal stakeholders also benefit from the ability to access and review contracts online, further enhancing efficiency. Overall, companies experience quicker contract execution and better collaboration between teams.

SOURCE Streamlines Contract Management

Contract generation delays in pharma clinical research are a common and avoidable issue. With Clinical Maestro SOURCE, companies can streamline the entire process, automating contract creation and eliminating inefficiencies. By reducing manual work and accelerating document review, companies can focus on executing trials and delivering successful outcomes faster.